Metformin, sitagliptin
Sold as Situviamet, Metsitag, Situmace, Metplitin co, Zitagluc plus, Sitagliptin/metformin sun pharma, Metjenta, Aslitamin, Simedab, Jantaform, Salumet xr
(3R)-3-Amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one
Drag to rotate. Structure from PubChem CID 4369359.
Background
Registration
- Applicants
- 9
- Registrations
- 26
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Cipla Medpro (Pty) Ltd | Situviamet | 50 mg/500 mg, 50 mg 000 mg /1 | 540497, 540498 | S3 | None |
| Macleods Pharmaceuticals SA (Pty) Ltd | Metsitag | 50/500, 50/1000 | 560317, 560318 | Not determined | None |
| Pharma Dynamics (Pty) Ltd | Situmace | 000 mg 50/1, 50/850 mg | 560725, 560726 | Not determined | None |
| Dr Reddyæs Laboratories (Pty) LtdCertificate held by Dr. Reddyâs Laboratories (Pty) Ltd | Metplitin co | 50/850, 50 mg/850 mg, 50 mg/1000 mg | 560994, 560995 | S3 | PIPIL |
| Ranbaxy Pharmaceutical (Pty) Ltd | Zitagluc plus, Sitagliptin/metformin sun pharma | 50/500, 50/850, 50/1 000 | 570065, 570066, 570068.065, 570069.066, 570070.067 | Not determined | None |
| Elttab Pharmaceuticals CC | Metjenta | 50/850, 50/1 000 | 570269, 570270 | Not determined | None |
| Ascend Laboratories (Pty) Ltd | Aslitamin | 50 mg/500 mg, 50 mg 000 mg /1 | 570904, 570905 | Not determined | None |
| Hetero Drugs South Africa (Pty) Ltd | Simedab, Jantaform | 50/500, 50/850, 50/1 000 | 590154, 590155, 590156, 590157.154, 590158.155, 590159.156 | Not determined | None |
| Zydus Healthcare (Pty) Ltd | Salumet xr | 50/500, 50/1 000, 100/1 000 | 590500, 590501, 590502 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Situviamet 50 mg/500 MG EACH TABLET CONTAINS METFORMIN HYDROCHLORIDE 500,0 mg; SITAGLIPTIN PHOSPHATE EQUIVALENT TO SITAGLIPTIN 50,0 mg | 50 mg/500 mg | 54049754/21.2/0497 | Registered | S3 | None |
| Situviamet 50 mg/1 000 MG ECAH TABLET CONTAINS METFORMIN HYDROCHLORIDE 1 000,0 mg SITAGLIPTIN PHOSPHATE EQUIVALENT TO SITAGLIPTIN 50,0 mg | 50 mg 000 mg /1 | 54049854/21.2/0498 | Registered | S3 | None |
| Metsitag 50/500 EACH TABLET CONTAINS SITAGLIPTIN PHOSPHATE MONOHYDRATE EQUIVALENT TO SITAGLIPTIN 50,0 mg & METFORMIN HYDROCHLORIDE 500,0 mg | 50/500 | 56031756/21.2/0317 | Registered | Not determined | None |
| Metsitag 50/1000 EACH TABLET CONTAINS SITAGLIPTIN PHOSPHATE MONOHYDRATE EQUIVALENT TO SITAGLIPTIN 50,0 mg & METFORMIN HYDROCHLORIDE 1000,0 mg | 50/1000 | 56031856/21.2/0318 | Registered | Not determined | None |
| Situmace 50/850 MG EACH TABLET CONTAINS SITAGLIPTIN PHOSPHATE MONOHYDRATE EQUIVALENT TO SITAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 850,0 mg | 50/850 mg | 56072556/21.2/0725 | Registered | Not determined | None |
| Situmace 50/1 000 MG EACH TABLET CONTAINS SITAGLIPTIN PHOSPHATE MONOHYDRATE EQUIVALENT TO SITAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 1000,0 mg | 000 mg 50/1 | 56072656/21.2/0726 | Registered | Not determined | None |
| Metplitin co 50/850 EACH TABLET CONTAINS SITAGLIPTIN HYDROCHLORIDE MONOHYDRATE 50,0 mg METFORMIN HYDROCHLORIDE 850,0 mg | 50/850Tablet | 56099465/21.2/0994Approved 1 October 2024 | Registered | S3 | PIPIL |
| Metplitin co 50/1 000 EACH TABLET CONTAINS SITAGLIPTIN HYDROCHLORIDE MONOHYDRATE 50,0 mg METFORMIN HYDROCHLORIDE 1 000,0 mg | 50 mg/850 mg, 50 mg/1000 mgTablet | 56099556/21.2/0995Approved 1 October 2024 | Registered | S3 | PIPIL |
| Zitagluc plus 50/500 EACH TABLET CONTAINS: SITAGLIPTIN FUMARATE EQUIVALENT TO SITAGLIPTIN 50,0 mg ,METFORMIN HYDROCHLORIDE 500,0 mg | 50/500 | 57006557/21.2/0065 | Registered | Not determined | None |
| Zitagluc plus 50/850 EACH TABLET CONTAINS: SITAGLIPTIN FUMARATE EQUIVALENT TO SITAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 850,0 mg | 50/850 | 57006657/21.2/0066 | Registered | Not determined | None |
| Sitagliptin/metformin 50/500 sun pharma EACH TABLET CONTAINS: SITAGLIPTIN FUMARATE EQUIVALENT TO SITAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 500,0 mg | 50/500 | 570068.06557/21.2/0068.065 | Registered | Not determined | None |
| Sitagliptin/metformin 50/850 sun pharma EACH TABLET CONTAINS: SITAGLIPTIN FUMARATE EQUIVALENT TO SITAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 850,0 mg | 50/850 | 570069.06657/21.2/0069.066 | Registered | Not determined | None |
| Sitagliptin/metformin 50/1 000 sun pharma EACH TABLET CONTAINS: SITAGLIPTIN FUMARATE EQUIVALENT TO SITAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 1 000,0 mg | 50/1 000 | 570070.06757/21.2/0070.067 | Registered | Not determined | None |
| Metjenta 50/850 EACH TABLET CONTAINS: SITAGLIPTIN PHOSPHATE MONOHYDRATE EQUIVALENT TO SITAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 850,0 mg | 50/850 | 57026957/21.2/0269 | Registered | Not determined | None |
| Metjenta 50/1 000 EACH TABLET CONTAINS: SITAGLIPTIN PHOSPHATE MONOHYDRATE EQUIVALENT TO SITAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 1000,0 mg | 50/1 000 | 57027057/21.2/0270 | Registered | Not determined | None |
| Aslitamin 50 mg/500 MG EACH TABLET CONTAINS: SITAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 500,0 mg | 50 mg/500 mg | 57090457/21.2/0904 | Registered | Not determined | None |
| Aslitamin 50 mg/1 000 MG EACH TABLET CONTAINS: SITAGLIPTIN 50,0 mg ,METFORMIN HYDROCHLORIDE 1 000,0 mg | 50 mg 000 mg /1 | 57090557/21.2/0905 | Registered | Not determined | None |
| Simedab 50/500 EACH TABLET CONTAINS: SITAGLIPTIN PHOSPHATE EQUIVALENT TO SITAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 500,0 mg | 50/500 | 59015459/21.2/0154 | Registered | Not determined | None |
| Simedab 50/850 EACH TABLET CONTAINS: SITAGLIPTIN PHOSPHATE EQUIVALENT TO SITAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 850,0 mg | 50/850 | 59015559/21.2/0155 | Registered | Not determined | None |
| Simedab 50/1 000 EACH TABLET CONTAINS: SITAGLIPTIN PHOSPHATE EQUIVALENT TO SITAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 1 000,0 mg | 50/1 000 | 590156 | Registered | Not determined | None |
| Jantaform 50/500 EACH TABLET CONTAINS: SITAGLIPTIN PHOSPHATE EQUIVALENT TO SITAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 500,0 mg | 50/500 | 590157.154 | Registered | Not determined | None |
| Jantaform 50/850 EACH TABLET CONTAINS: SITAGLIPTIN PHOSPHATE EQUIVALENT TO SITAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 850,0 mg | 50/850 | 590158.15559/21.2/0158.155 | Registered | Not determined | None |
| Jantaform 50/1 000 EACH TABLET CONTAINS: SITAGLIPTIN PHOSPHATE EQUIVALENT TO SITAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 1 000,0 mg | 50/1 000 | 590159.15659/21.2/0159.156 | Registered | Not determined | None |
| Salumet 50/500 xr EACH TABLET CONTAINS: SITAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 500,0 mg | 50/500 | 59050059/21.2/0500 | Registered | Not determined | None |
| Salumet 50/1 000 xr EACH TABLET CONTAINS: SITAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 1 000,0 mg | 50/1 000 | 59050159/21.2/0501 | Registered | Not determined | None |
| Salumet 100/1 000 xr EACH TABLET CONTAINS: SITAGLIPTIN 100,0 mg METFORMIN HYDROCHLORIDE 1 000,0 mg | 100/1 000 | 59050259/21.2/0502 | Registered | Not determined | None |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Metformin hydrochloride, sitagliptin phosphate equivalent to sitagliptin
S3: Sitagliptin phosphate
Consolidated Schedules 06 July 2026, line 4249
Pharmacological class: Oral hypoglycaemics. (class 21.2)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Metplitin co 50/850, Dr Reddyæs Laboratories (Pty) Ltd is scheduled S3 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.